IDH1 and neoplasm: Moreover, IDH mutations promote tumorigenesis by decreasing intracellular levels of NADPH, which also has the effect of increasing the sensitivity of tumor cells to cytotoxic therapies, accounting for the positive prognostic value of this marker (see [10] for a review).